Investigation of the pan-cancer property of SDC1 and its expression pattern affected patients’ overall survival for breast cancer

Yao Song; Ming‐De Lu; Qifeng Luo; Chunhua Lu; Xiaofeng Xu; Sibo Yuan; Bin Xu; Hua Huang; Qing Lin

doi:10.1007/s12672-025-04139-x

Affiliated Institutions

Related Publications

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer

Rashmi K. Murthy , Sherene Loi , Alicia Okines +29 more

In heavily pretreated patients with HER2-positive metastatic breast cancer, including those with brain metastases, adding tucatinib to trastuzumab and capecitabine resulted in b...

2019 New England Journal of Medicine 1224 citations

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer

Nicholas C. Turner , Dennis J. Slamon , Jungsil Ro +16 more

Among patients with hormone-receptor-positive, HER2-negative advanced breast cancer who had sensitivity to previous endocrine therapy, treatment with palbociclib-fulvestrant res...

2018 New England Journal of Medicine 1180 citations

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.

Alexander Paterson , T.J. Powles , John А. Kanis +3 more

PURPOSE Osteolytic metastases often give rise to hypercalcemia, fracture, and bone pain, and occur commonly in patients with recurrent breast cancer. We assessed the bisphosphon...

1993 Journal of Clinical Oncology 554 citations

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés , David W. Cescon , Hope S. Rugo +97 more

Pembrolizumab monotherapy showed durable antitumour activity and manageable safety in patients with metastatic triple-negative breast cancer. We aimed to examine whether the add...

2020 The Lancet 1658 citations

The prognostic landscape of genes and infiltrating immune cells across human cancers

Andrew J. Gentles , Aaron M. Newman , Chih Long Liu +11 more

Molecular profiles of tumors and tumor-associated cells hold great promise as biomarkers of clinical outcomes. However, existing data sets are fragmented and difficult to analyz...

2015 Nature Medicine 3132 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Investigation of the pan-cancer property of SDC1 and its expression pattern affected patients’ overall survival for breast cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Yao Song, 
                                
                                    Ming‐De Lu, 
                                
                                    Qifeng Luo
                                
                                et al.
                            
                            (2025). 
                            Investigation of the pan-cancer property of SDC1 and its expression pattern affected patients’ overall survival for breast cancer. 
                            Discover Oncology
                            
                            .
                            https://doi.org/10.1007/s12672-025-04139-x

Identifiers

DOI: 10.1007/s12672-025-04139-x